Cargando…

Development and optimization of buspirone oral osmotic pump tablet

The aim of the current study was to design a porous osmotic pump–based drug delivery system for controlling the release of buspirone from the delivery system. The osmotic pump was successfully developed using symmetric membrane coating. The core of the tablets was prepared by direct compression tech...

Descripción completa

Detalles Bibliográficos
Autores principales: Derakhshandeh, K., berenji, M. Ghasemnejad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314871/
https://www.ncbi.nlm.nih.gov/pubmed/25657794
_version_ 1782355385120718848
author Derakhshandeh, K.
berenji, M. Ghasemnejad
author_facet Derakhshandeh, K.
berenji, M. Ghasemnejad
author_sort Derakhshandeh, K.
collection PubMed
description The aim of the current study was to design a porous osmotic pump–based drug delivery system for controlling the release of buspirone from the delivery system. The osmotic pump was successfully developed using symmetric membrane coating. The core of the tablets was prepared by direct compression technique and coated using dip-coating technique. Drug release from the osmotic system was studied using USP paddle type apparatus. The effect of various processing variables such as the amount of osmotic agent, the amount of swellable polymer, concentration of the core former, concentration of the plasticizer, membrane thickness, quantum of orifice on drug release from osmotic pump were evaluated. Different kinetic models (zero order, first order and Higuchi model) were applied to drug release data in order to establish the kinetics of drug release. It was found that the drug release was mostly affected by the amount of NaCl as osmotic agent, the swellable polymer; hydroxy propyl methyl cellulose (HPMC), the amount of PEG-400 and cellulose acetate in the coating solution and thickness of the semipermeable membrane. The optimized formulation released buspirone independent of pH and orifice quantum at the osmogen amount of 42%, hydrophilic polymer of 13% and pore size of 0.8 mm on the tablet surface. The drug release of osmotic formulation during 24 h showed zero order kinetics and could be suggested that this formulation as a once-daily regimen improves pharmacokinetic parameters of the drug and enhances patient compliance.
format Online
Article
Text
id pubmed-4314871
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-43148712015-02-05 Development and optimization of buspirone oral osmotic pump tablet Derakhshandeh, K. berenji, M. Ghasemnejad Res Pharm Sci Original Article The aim of the current study was to design a porous osmotic pump–based drug delivery system for controlling the release of buspirone from the delivery system. The osmotic pump was successfully developed using symmetric membrane coating. The core of the tablets was prepared by direct compression technique and coated using dip-coating technique. Drug release from the osmotic system was studied using USP paddle type apparatus. The effect of various processing variables such as the amount of osmotic agent, the amount of swellable polymer, concentration of the core former, concentration of the plasticizer, membrane thickness, quantum of orifice on drug release from osmotic pump were evaluated. Different kinetic models (zero order, first order and Higuchi model) were applied to drug release data in order to establish the kinetics of drug release. It was found that the drug release was mostly affected by the amount of NaCl as osmotic agent, the swellable polymer; hydroxy propyl methyl cellulose (HPMC), the amount of PEG-400 and cellulose acetate in the coating solution and thickness of the semipermeable membrane. The optimized formulation released buspirone independent of pH and orifice quantum at the osmogen amount of 42%, hydrophilic polymer of 13% and pore size of 0.8 mm on the tablet surface. The drug release of osmotic formulation during 24 h showed zero order kinetics and could be suggested that this formulation as a once-daily regimen improves pharmacokinetic parameters of the drug and enhances patient compliance. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4314871/ /pubmed/25657794 Text en Copyright: © Research in Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Derakhshandeh, K.
berenji, M. Ghasemnejad
Development and optimization of buspirone oral osmotic pump tablet
title Development and optimization of buspirone oral osmotic pump tablet
title_full Development and optimization of buspirone oral osmotic pump tablet
title_fullStr Development and optimization of buspirone oral osmotic pump tablet
title_full_unstemmed Development and optimization of buspirone oral osmotic pump tablet
title_short Development and optimization of buspirone oral osmotic pump tablet
title_sort development and optimization of buspirone oral osmotic pump tablet
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314871/
https://www.ncbi.nlm.nih.gov/pubmed/25657794
work_keys_str_mv AT derakhshandehk developmentandoptimizationofbuspironeoralosmoticpumptablet
AT berenjimghasemnejad developmentandoptimizationofbuspironeoralosmoticpumptablet